B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CD47

MOLECULAR TARGET

CD47 molecule

UniProt: Q08722NCBI Gene: 9615 compounds

CD47 (CD47 molecule) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CD47

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Aurintricarboxylic Acid1.102
2Histidine0.691
3Fusaric Acid0.691
4Idarubicin0.691
5Mimosine 3-Hydroxy-4-oxo-1(4H)-pyridinealanine.0.691

About CD47 as a Drug Target

CD47 (CD47 molecule) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented CD47 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CD47 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.